OTC Markets EXMKT - Delayed Quote USD
Kaleido Biosciences, Inc. (KLDO)
0.0050
0.0000
(0.00%)
At close: April 23 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | -- | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MENICHELLA DANIEL L. Chief Executive Officer | Purchase at price 11.50 per share. | Direct | 230,000 | Feb 8, 2021 |
| FLAGSHIP VENTURES FUND IV GENERAL PARTNER L L C Beneficial Owner of more than 10% of a Class of Security | Purchase at price 11.50 per share. | Indirect | 2,472,500 | Feb 8, 2021 |
| MELAS-KYRIAZI THEO Director | Purchase at price 7.50 per share. | Direct | 249,998 | Jun 4, 2020 |
| FLAGSHIP VENTURES FUND IV GENERAL PARTNER L L C Beneficial Owner of more than 10% of a Class of Security | Purchase at price 7.50 per share. | Indirect | 15,000,000 | Jun 4, 2020 |
| QUINN ANTHONY G Director | -- | Direct | -- | Mar 4, 2019 |
| FLAGSHIP VENTURES FUND V GENERAL PARTNER L.L.C Beneficial Owner of more than 10% of a Class of Security | Purchase at price 15.00 per share. | Indirect | 13,999,995 | Mar 4, 2019 |
| FLAGSHIP VENTURES FUND V GENERAL PARTNER L.L.C Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Mar 4, 2019 |
| FLAGSHIP VENTURES FUND IV GENERAL PARTNER L L C Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Mar 4, 2019 |
| BONNEY MICHAEL W Officer and Director | -- | Indirect | -- | Mar 4, 2019 |
| VON MALTZAHN GEOFFREY Director | -- | Direct | -- | Mar 4, 2019 |
| BONNEY MICHAEL W Officer and Director | Purchase at price 13.95 - 14.65 per share. | Direct | 999,492 | Feb 28, 2019 |
Related Tickers
UCBJF UCB SA
150.70
0.00%
BIOCON.BO Biocon Limited
326.40
-2.81%
ENLV.TA Enlivex Therapeutics Ltd.
335.40
+1.45%
EVLO Evelo Biosciences, Inc.
0.0005
0.00%
OPT Opthea Limited
3.4100
+1.49%
JSPR Jasper Therapeutics, Inc.
4.5600
+4.35%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.4200
+9.23%
IOBT IO Biotech, Inc.
0.9400
+1.12%
PRLD Prelude Therapeutics Incorporated
0.8832
-5.91%
ACET Adicet Bio, Inc.
0.6014
+3.39%